Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Accounts Payables: 2009-2022

Historic Accounts Payables for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Sep 2022 value amounting to $2.5 million.

  • Avadel Pharmaceuticals' Accounts Payables fell 63.94% to $2.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.5 million, marking a year-over-year decrease of 63.94%. This contributed to the annual value of $7.7 million for FY2021, which is 161.72% up from last year.
  • According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Accounts Payables is $2.5 million, which was down 66.12% from $7.3 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Accounts Payables high stood at $15.9 million for Q1 2018, and its period low was $2.5 million during Q3 2022.
  • Its 3-year average for Accounts Payables is $5.1 million, with a median of $5.1 million in 2021.
  • In the last 5 years, Avadel Pharmaceuticals' Accounts Payables plummeted by 73.91% in 2019 and then skyrocketed by 161.72% in 2021.
  • Over the past 5 years, Avadel Pharmaceuticals' Accounts Payables (Quarterly) stood at $3.5 million in 2018, then surged by 74.14% to $6.1 million in 2019, then slumped by 51.90% to $2.9 million in 2020, then surged by 161.72% to $7.7 million in 2021, then crashed by 63.94% to $2.5 million in 2022.
  • Its last three reported values are $2.5 million in Q3 2022, $7.3 million for Q2 2022, and $6.0 million during Q1 2022.